Designed to balance blood sugar levels in patients with type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists gained fame through a distinct and significant side effect: weight loss
Bariatric surgery involves major surgical intervention and carries both short-term surgical risks and long-term nutritional considerations
Measure the Right Things: Just tracking Total Testosterone isn't enough
But be extra careful with your measurements, since the higher concentration means each unit contains more tirzepatide, and errors have a bigger impact
This rapid increase in prescription rates followed the recent approval of two GLP-1R agonists, semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), for weight management in obese or overweight patients
2023, www.health.harvard.edu/staying-healthy/understanding-new-weight-loss-drugs#:~:text=Two%20of%20these%20GLP%2D1.